N1CCC([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][C:8]=2[C@@H:13]([NH:15][C:16](=[O:18])[CH3:17])[CH3:14])CC1.Br[C:20]1[CH:27]=[CH:26][C:25]([O:28][CH2:29][CH2:30][CH3:31])=[CH:24][C:21]=1[C:22]#[N:23].C(=O)([O-])[O-].[K+].[K+].[NH:38]1[CH2:45][CH2:44][CH2:43][C@H:39]1[C:40](O)=O>CS(C)=O.[Cu]I.O>[C:22]([C:21]1[CH:24]=[C:25]([O:28][CH2:29][CH2:30][CH3:31])[CH:26]=[CH:27][C:20]=1[N:38]1[CH2:45][CH2:44][CH:43]([C:11]2[CH:10]=[CH:9][C:8]([C@@H:13]([NH:15][C:16](=[O:18])[CH3:17])[CH3:14])=[CH:7][CH:12]=2)[CH2:39][CH2:40]1)#[N:23]100 mg (0.41 mmol) (S)—N-[1-(Piperidin-4-yl-phenyl)-ethyl]-acetamide (V.1) in 2 mL DMSO are added to a mixture of 97 mg (0.41 mmol) 2-bromo-5-propoxy-benzonitrile, 112 mg (0.82 mmol) potassium carbonate, 7.7 mg (0.041 mmol) copper(I) iodide and 9 mg (0.08 mmol) (L)-proline under inert gas atmosphere. The mixture is stirred for 7 d at 90° C. After that time, water is added and the mixture is extracted with ethyl acetate. The organic layer is dried over sodium sulphate and the solvent is removed in vacuo. The residue is purified by HPLC (column: Waters XBridge 5 μM; eluent A: water+0.3% NH4OH, eluent B: MeOH) to yield the desired product.